NN-390
NN-390 is a potent and selective HDAC6 inhibitor, with an IC50 of 9.8 nM. NN-390 penetrates the blood-brain barrier (BBB). NN-390 shows study potential in metastatic Group 3 MB (medulloblastoma).
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2490284-25-6
- 分子式: C17H16F4N2O4S
- 分子量:420.38
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
|
HDAC6 9.8 nM (IC50) |
HDAC3 >1 μM (IC50) |
HDAC8 >1 μM (IC50) |
HDAC11 >1 μM (IC50) |
HDAC1 >5 μM (IC50) |
HDAC2 >5 μM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Fibroblast | IC50 |
12.4 μM
Compound: 5a; NN-390
|
Cytotoxicity against primary normal human fibroblast cells assessed as inhibition of cell growth incubated for 72 hrs measured by spectrophotometer analysis
Cytotoxicity against primary normal human fibroblast cells assessed as inhibition of cell growth incubated for 72 hrs measured by spectrophotometer analysis
|
[PMID: 35119267] |
| Fibroblast | IC50 |
8.8 μM
Compound: 5a; NN-390
|
Cytotoxicity against human primary pooled fibroblasts cells assessed as inhibition of cell growth incubated for 72 hrs measured by spectrophotometer analysis
Cytotoxicity against human primary pooled fibroblasts cells assessed as inhibition of cell growth incubated for 72 hrs measured by spectrophotometer analysis
|
[PMID: 35119267] |
| HUVEC | IC50 |
10.1 μM
Compound: 5a; NN-390
|
Cytotoxicity against HUVEC cells assessed as inhibition of cell growth incubated for 72 hrs measured by spectrophotometer analysis
Cytotoxicity against HUVEC cells assessed as inhibition of cell growth incubated for 72 hrs measured by spectrophotometer analysis
|
[PMID: 35119267] |
| MM1.S | IC50 |
1.38 μM
Compound: 5a; NN-390
|
Cytotoxicity against human MM1.S cells assessed as inhibition of cell growth incubated for 72 hrs measured by spectrophotometer analysis
Cytotoxicity against human MM1.S cells assessed as inhibition of cell growth incubated for 72 hrs measured by spectrophotometer analysis
|
[PMID: 35119267] |
| MV4-11 | IC50 |
1.19 μM
Compound: 5a; NN-390
|
Cytotoxicity against human MV4-11 cells assessed as inhibition of cell growth incubated for 72 hrs measured by spectrophotometer analysis
Cytotoxicity against human MV4-11 cells assessed as inhibition of cell growth incubated for 72 hrs measured by spectrophotometer analysis
|
[PMID: 35119267] |
| NSC | IC50 |
5.76 μM
Compound: 5a; NN-390
|
Cytotoxicity against human fetal neuronal stem cells assessed as inhibition of cell growth incubated for 72 hrs measured by spectrophotometer analysis
Cytotoxicity against human fetal neuronal stem cells assessed as inhibition of cell growth incubated for 72 hrs measured by spectrophotometer analysis
|
[PMID: 35119267] |
NN-390 exhibits cellular potency with IC50 values of 1.19 μM in MV4-11 cells and 1.38 μM in MM.1S cells while having minimal effects on noncancerous counterparts (IC50 > 50 μM in MRC-9)[1].
NN-390 (72 h) strongly decreases proliferation in HD-MB03 cells, with an IC50 of 0.13 μM, and significantly impairs self-renewal of BTIC-enriched HD-MB03s[1].
NN-390 (0-2 μM, 1 h) markedly increases acetylation of α-tubulin and minimally changes acetylated histone H3[1].
NN-390 (6 h) results in acetylation of α-tubulin from concentrations as low as 0.1 μM (0-0.2 μM), and dose-dependent increases in acetylation of α-tubulin (0-0.2 μM)[1].
NN-390 (0-2 μM, 24 h) promotes cancer cells apoptosis in MV4-11 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HeLa cells[1]
-
Concentration:0, 0.1, 0.25, 1, 2 μM
-
Incubation Time:1 h
-
Result:Markedly increased acetylation of α-tubulin and minimally changed acetylated histone H3.
-
Cell Line:AML (MV4-11) cells[1]
-
Concentration:0, 0.1, 0.5, 1, 5 μM
-
Incubation Time:6 h
-
Result:Resulted in acetylation of α-tubulin from concentrations as low as 0.1 μM and with limited acetylation of histone H3 at only the highest concentration of 5 μM.
-
Cell Line:Group 3 MB (HD-MB03) cells[1]
-
Concentration:0, 0.053, 0.106, 0.158, 0.211 μM
-
Incubation Time:6 h
-
Result:Dose-dependent increased in acetylation of α-tubulin from the lowest concentration of 53 nM, with no observable change in acetylation of off-target histone H3 up to 211 nM.
-
Cell Line:MV4-11 cells[1]
-
Concentration:0, 0.25, 0.75, 1, 2 μM
-
Incubation Time:24 h
-
Result:Promoted cancer cells apoptosis, 39% of cancer cells were undergoing late-stage apoptosis after 18 h at 2 μM, and 11% of cells were in the late apoptosis stage at 0.25 μM.
NN-390 can improve PAMPA (parallel artificial membrane permeability assay)-BBB (blood-brain barrier) score[1].
Pharmacokinetic Parameters of NN-390 in male male CD-1 mice[1].
| Compound | KT-531 | 5a; NN-390 |
| t1/2 (h) | 1.05 | 1.90 |
| Cmax (ng/mL) | 493 | 750 |
| AUClast (h*ng/mL) | 1576 | 2523 |
| AUClnf (h*ng/mL) | 1519 | 2548 |
| AUC/D (h*ng/mL) | 79 | 126 |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:CD-1 mice (male, n=3)[1]
-
Dosage:20 mg/kg
-
Administration:IP, single dose (Pharmacokinetic Analysis)
-
Result:Had a half-life of 115 min in human plasma, a 2.8-fold increase in stability.
化学情報
-
CAS 番号 2490284-25-6
-
分子量 420.38
-
分子式 C17H16F4N2O4S
-
SMILES
O=C(NO)C1=CC=C(CN(C(C)C)S(=O)(C2=CC(F)=C(F)C(F)=C2F)=O)C=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)